Transaction · 0001805688-25-000013

Iannone Robert

Iannone Robert, EVP, GR, DC, reported a transaction classified as withholding at Jazz Pharmaceuticals plc involving 2181.000000 shares for an estimated $267434.22. Reported holdings after the transaction were 67766.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

withholdingSEC transaction code FEVP, GR, DC
JAZZJazz Pharmaceuticals plc
Filing timeJan 22
Trade dateJan 17, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

JAZZ price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
JAZZ since 2025-01-22Filed 589 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
withholding
Code F
Identifier
0001805688-25-000013
Ordinary Shares
Transaction date
Jan 17, 2025
Filed Jan 22, 2025, 11:58 PM · 5d delay
Shares
2.18k sh
$12.2k per share
Estimated value
-$26.7M
Computed from shares × price
Holdings after
67.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, G R&D and CMO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting…

  2. F2

    The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan.

  3. F3

    Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.

Original filing · 0001805688-25-000013
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

JAZZ